Disseminated paracoccidioidomycosis with peripleuritis in an AIDS patient by Corti, Marcelo et al.
Rev. Inst. Med. trop. S. Paulo
46(1):47-50, January-February, 2004
Unit 10 and Mycology Unit, Infectious Diseases F.J. Muñiz Hospital, Buenos Aires, Argentina.
Correspondence to: Marcelo Corti, Puán 381 2° C1406CQG, Buenos Aires, Argentina. e-mail: marcelocorti@ciudad.com.ar
DISSEMINATED PARACOCCIDIOIDOMYCOSIS WITH PERIPLEURITIS IN AN AIDS PATIENT
Marcelo CORTI, María F. VILLAFAÑE, Ricardo NEGRONI & Omar PALMIERI
SUMMARY
Paracoccidioidomycosis is one of the most frequent systemic and endemic mycoses of Latin America caused by a dimorphic
fungus. In AIDS patients, paracoccidioidomycosis appears as a severe and disseminated disease with a wide spectrum of clinical
findings. The CD4 counts are usually less than 200 cell/µL. We present a case of disseminated paracoccidioidomycosis with peripleuritis
and subcutaneous abscesses on the chest wall as initial manifestation of AIDS. In endemic countries, paracoccidioidomycosis should
be included as an opportunistic infection in AIDS.
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INTRODUCTION
Paracoccidioidomycosis (PCM), South American Blastomycosis or
Lutz disease, is a systemic mycosis caused by the thermodimorphic
fungus, Paracoccidioides brasiliensis (Pb). It is an endemic mycosis of
humid, tropical and subtropical areas, and limited to Central and South
America, from Mexico to Argentina. The disease is generally seen in
poor people living in rural areas, it has also been described in nonendemic
areas, however always in subjects who had lived in or had visited Latin
America6,7,14.
In normal hosts, Pb infection is associated with a wide spectrum of
clinical aspects; PCM has occasionally been observed in patients with
cellular immunity impairment. In patients infected by the human
immunodeficiency virus type-1 (HIV-1), the frequency of PCM is low
in comparison with other mycoses, such as cryptococcosis and
histoplasmosis12,13,18,19.
The first cases of this mycosis in AIDS patients were reported in
1989 and, until 1995, 31 cases of this association had been reported3,11,26.
in Brazil, the estimated incidence of PCM in HIV-1 seropositive patients
in 1995 was 0.09%18.
We present a patient with advanced HIV/AIDS disease, who developed
a disseminated form of PCM with peripleuritis and subcutaneous abscesses
in the chest wall, as the initial manifestation of AIDS.
CASE REPORT
A 36-year-old, white heterosexual male, intravenous drug abuser,
and seropositive for human immunodeficiency virus type-1 (HIV-1), was
admitted to our service with prolonged fever, weight loss, anorexia and
headache. There was no prior history of opportunistic infections, but at
examination, his CD4 T count was 8 cell/µL, indicating advanced HIV/
AIDS disease. He reported no previous history of farming or rural
activities. Physical exam also showed enlargement of cervical lymph
nodes, hepatosplenomegaly and multiple subcutaneous abscesses on the
left chest wall and sternum. Chest X-ray revealed a lytic lesion of the 6th
and 10th rib, hilar enlargement with homolateral cisuritis, and
homogeneous consolidation on the left lower lobe from the thoracic
wall to the pulmonary parenchyma; this image was convex in the central
part and concave on both sides. The angles of union of this opacity with
the chest wall were obtuse (Fig. 1) as described by Skarby in 1939, for
peripleuritis or endothoracic fasciitis.
Computed tomography (CT) of the thorax showed osteolytic lesions
on the sternum and a soft tissue image in front of this. The parietal
pleura thickened at the level of the XII vertebra and there was the presence
of a soft tissue density mass and an osteolitic image of the rib at that
level (Fig. 2). Percutaneous needle aspiration of both subcutaneous
abscesses was performed and direct microscopic exam showed purulent
material and the presence of multiple budding yeast cells, characteristic
of Pb. Likewise, direct microscopic exam of sputum was positive for Pb.
The patient was treated with itraconazole (200 mg/day) during six
months and then, he received 100 mg/day as maintenance therapy.
After the first two months, antiretroviral therapy was initiated. One
year after onset of symptoms he is in good clinical condition with
improvement in his general state and resolution of adenopathy,
subcutaneous abscesses and radiological lesions.
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DISCUSSION
PCM is a rare complication in AIDS patients. In the 10 years after the
description of the first patients with this association, less than 50 cases
have been published in the medical literature3,8,11,13.14,16,27. In fact, the low
incidence of PCM in AIDS patients contrasts with the high frequency of
cryptococcosis and histoplasmosis in the same population1,2,4,9,20,22.
Moreover, cryptococcosis and histoplasmosis are associated with an
important number of deaths and a high morbidity rate in AIDS patients.
Pb infection has also been described, albeit rarely, in patients with
immunosuppressive diseases other than AIDS, such as solid organ transplant
recipients and patients with solid and hematological malignancies. Some
authors have suggested that the low incidence of PCM among patients with
AIDS in Latin America, might be related to the fact that many AIDS patients
receive trimethoprim-sulfamethoxazole and ketoconazole as a prophylaxis
or treatment for Pneumocystis carinii pneumonia (PCP) and oropharyngeal
candidiasis. Both these drugs are active against Pb infection25. Another
possible explanation could be that some cases of pulmonary PCM are
diagnosed and treated with co-trimoxazole as PCP (based only on clinical
and radiological findings) and both, PCM and PCP, respond to therapy with
trimethoprim-sulfamethoxazole. Finally, we should consider the fact that
AIDS is predominantly an urban disease in contrast with the rural prevalence
of PCM23.
Generally, patients with PCM associated with AIDS are severely
immunodepressed at the time of diagnosis, and the CD4 T counts are
below 100 cell/µL, as in the present case. PCM is a late complication in
AIDS patients and is reportedly the first opportunistic infection in only
31% of published cases, again similar to our patient.
Fig.1 - Chest-X-ray shows a lytic lesion of the 6th and 10th rib and a consolidation on the left
lower lobe.
Fig. 2 - Computed tomography of the thorax shows osteolytic lesions on the sternum and a soft tissue image in front of it and at the level of XII vertebra.
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PCM has multiple manifestations and three progressive clinical forms
have been recognized: acute, subacute and chronic. PCM associated with
AIDS presents as an acute disseminated form or a subacute juvenile form,
characterized by multisystemic organ involvement, including malaise,
prolonged fever, weight loss, hepatosplenomegaly, enlargement of cervical,
inguinal and axillary lymph nodes, cutaneous involvement in form of
papules or ulcerating lesions with necrotic areas, pulmonary infiltrates,
cerebral mass lesions, and bone involvement with osteomyelitis. Less than
60% of patients present pulmonary involvement12. Our patient also had
pleural involvement with peripleuritis and subcutaneous abscesses on the
chest wall with costal and sternal osteomyelitis. Bone involvement has
been frequently described in the disease5,10,15, although there is no reference
to the involvement of the endothoracic fascia with peripleuritis. This clinical
finding implies the involvement of pleuroparietal lymph nodes with
peripleural abscesses, some of which rupture through weak points in the
chest wall. In consequence, subcutaneous abscesses can develop, as seen
in the patient presented here.
Diagnosis of PCM is confirmed through the observation of
multibudding and birefringent yeast cells by direct microscopic
examination of biologic fluids (sputum, broncopulmonary secretions)
or histopathologic examination of skin and mucosal biopsies, and also
by the isolation of the fungus in cultures. Direct microscopic examination
is definitive and the gold standard method to identify the fungus in PCM
lesions17. Culture usually requires a long time, is less sensitive than direct
examination and has a high rate of negative results, especially if the
samples are contaminated or small in quantity2,21,23.
In our patient, direct examination of the purulent exudate obtained
from the subcutaneous abscess as well as from sputum samples revealed
multiple budding Pb yeast cells.
Histopathologic studies, including special stains, for example
Grocott’s methenamine-silver, are also very helpful for the diagnosis,
specially when the material is obtained by biopsy. The presence of yeast
with thick walls and multiple gemmation is a characteristic of Pb.
Serologic diagnosis relies on the detection of specific antibodies;
serologic reactions are useful both as a diagnosis and as a parameter for
disease activity assessment.
Methods for detecting circulating antibodies are positive in more
than 90% of patients with active disease; however, in AIDS patients, the
antibody levels are lower in comparison with patients without HIV.
According to the literature, specific antibodies have been detected in
only half of patients tested.
A cutaneous test with paracoccidioidin is negative in AIDS patients
and other immunocompromised subjects, in relation to the anergic form
of the disease17,23.
Itraconazole, a triazolic compound with good absorption, is the
treatment of choice. Itraconazole is used at an initial dose of 200 mg/day
for 3 months; after this, the dose has to be reduced to 100 mg/day. The
efficacy of itraconazole is higher than 93% with a relapse rate below 7%23,24.
The use of itraconazole may be associated with a generally asymptomatic
transitory elevation of hepatic enzyme levels. Determination of plasma
itraconazole levels is useful because some AIDS patients present
hypochlorhydria with lower levels of plasma drug concentration27.
The patient was treated with itraconazole and antiretroviral therapy
with a good clinical response and tolerance.
Finally, we suggest that in endemic countries, PCM should be
included among the opportunistic infections observed in AIDS patients.
RESUMEN
Paracoccidioidomicosis diseminada con peripleuritis en
paciente con SIDA
La paracoccidioidomicosis es una de las micosis sistémicas
endémicas más frecuentes de Latinoamérica, causada por un hongo
dimorfo. En los pacientes con SIDA se presenta como una enfermedad
grave y diseminada, con un amplio espectro de manifestaciones clínicas.
Los niveles de linfocitos T CD4 + son habitualmente < de 200 cél/µL.
Presentamos un caso de paracoccidioidomicosis diseminada con
peripleuritis y abscesos subcutáneos sobre la pared torácica como
manifestación inicial del SIDA. En países endémicos, la paracocci-
dioidomicosis debe incluirse como una complicación oportunista de los
pacientes con SIDA.
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